« Return to News | Technology Solutions

Clintrak launches digital labeling service The DigiPly

Friday, September 6, 2013 03:03 PM

Clintrak, a clinical trial label company, has launched The DigiPly, a digital label service with benefits including enhanced turnaround times, quality control and flexible label options.

The service is the clinical supply chain industry’s first digitally produced booklet label service supported by a team of clinical supply professionals. It provides flexibility in labeling, including the ability to add or delete countries within days instead of weeks, thus avoiding costly delays.

The service was designed to mitigate risk through quality-driven technology and production processes. A fully automated, proprietary process inspects 100% of label text for accuracy and readability and identifies text that is illegible for any reason.

Other features of The DigiPly service enhance ease of use by clinical sites and study patients include over 100 pages of available text, with space for larger, easier-to-read font sizes, color options that permit the highlighting of text and inclusion of logos, a label cover page made of a flexible polymer that won’t tear upon application or use and that can tolerate most temperature ranges and full lamination that protects data integrity and prevents smudging or damage in transit or at investigative sites.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.